Fundraising Fox

Peter Svennilson

Investor

Managing Partner at The Column Group

San Francisco, California

Writes $100K – $5M checks · typically $1.5M

About

Peter Svennilson led Aragon to a ~$1B J&J sale and chaired Seragon to a Genentech/Roche exit; as an Institute for Advanced Study Trustee he links theoretical science with translational creation.

Invests in

BiotechHealthtech

Experience

  1. The Column GroupManaging Partner and Foundercurrent2007 — presentSan Francisco Bay Area
  2. Three Crowns CapitalManaging Partner and Founder1996 — 2006

Education

  1. Stockholm School of EconomicsMaster of Business Administration (MBA), Business Administration and Management1982 — 1985
  2. London Business SchoolStudies at MBA Program
  3. INSEADStudies at MBA Program

Same school

Deals · 3

Circle PharmaBoard seat

via The Column Group · filed Mar 2020 · $45M raise

Constellation PharmaceuticalsBoard seat

via The Column Group · filed Apr 2018 · $100M raise

Ngm BiopharmaceuticalsBoard seat

via The Column Group · filed Feb 2015 · $60M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at The Column Group